Walgreens vs Rite Aid used to be an ordinary drugstore rivalry. In 2026 it is the sharpest distress case study in net lease: one tenant went private under Sycamore Partners in August 2025 with its ratings withdrawn and 1,200 store closures underway, and the other ceased to exist entirely, closing every remaining store by October 2025 after a second Chapter 11. Neither company meets the investment grade threshold of BBB‑/Baa3, and together they show exactly what happens to net lease real estate on the wrong side of that line.
This page compares the two credits the way the investment grade guide frames all tenant underwriting: what the rating says, what the lease is actually worth, and what the real estate is worth if the tenant fails. For pharmacy investors, the comparison is no longer about which tenant to prefer. It is about how to underwrite a distressed operating credit versus a dark box, and what both mean for the cap rates buyers are being offered.
Walgreens vs Rite Aid: Head-to-Head Comparison
| Metric | Walgreens | Rite Aid |
|---|---|---|
| Ownership | Private (Sycamore Partners, Aug 2025) | Chapter 11 wind-down (Case No. 25-14861, D.N.J.) |
| S&P / Moody’s Rating | NR — ratings withdrawn (formerly BB‑/Ba3) | D / Ca — default, obligations extinguished |
| Investment Grade? | No — below BBB‑/Baa3 before withdrawal | No — defunct, all stores closed Oct 2025 |
| US Locations | ~7,500 (1,200 closures planned over 3 years) | 0 operating (peak ~4,600; 1,240 at 2nd filing) |
| Cap Rate Range (2026) | 8.6% – 9.5% | N/A — dark-box / alternative-use pricing |
| Typical Lease Term | 25 years (legacy leases) | Leases rejected or assigned in bankruptcy |
| Guarantee | Corporate, value diminished post-privatization | Extinguished in Chapter 11 |
| Typical Building | 12,000–14,500 SF on 1.5–2.0 acres | 10,000–13,500 SF prototype |
| Typical Price Range | $2.5M – $6.0M | $1.0M – $3.5M (former locations) |
| Revenue | $147.0B (FY2024, last public) | None — operations ceased |
Credit Rating: Withdrawn vs Defaulted
Walgreens Boots Alliance went private on August 28, 2025, when Sycamore Partners completed its $10 billion take-private after roughly a century of public ownership. The company’s last public ratings were BB‑ from S&P and Ba3 from Moody’s, already non-investment-grade, and those ratings were withdrawn at privatization. The business was split into five entities, including the US retail pharmacy, Boots in the UK, Shields, CareCentrix, and VillageMD, and a 1,200-store closure program is running through 2028. Analysts have openly flagged bankruptcy risk if operations do not stabilize under the new leverage. The full timeline is on the Walgreens credit rating and cap rate page.
Rite Aid is past tense. After a first Chapter 11 in 2023–2024 fixed the balance sheet but not the business, vendors tightened trade terms, shelves emptied, and a second filing followed on May 5, 2025 as a Section 363 wind-down. Pharmacy scripts were auctioned to CVS, Walgreens, Kroger, Albertsons, and Giant Eagle, and by October 2025 every store had closed. The rating is D/Ca and the corporate guarantee behind former Rite Aid leases is extinguished. Details are on the Rite Aid credit rating page, and the full ratings landscape is tracked in the credit tenant ratings database.
The cutoff lesson: in 2015, both chains were rated within two notches of each other below the BBB‑ line. A decade later, one trades at 9% cap rates on bankruptcy watch and the other’s guarantee is legally worthless. Sub-investment-grade pharmacy credit did not mean modestly higher risk; it meant an entirely different distribution of outcomes.
Cap Rates: Distress Pricing vs Dark-Box Pricing
Walgreens NNN properties trade at 8.6–9.5%, roughly 200+ basis points wide of investment grade pharmacy comparables and among the highest cap rates of any national-brand net lease product. That yield is compensation for real hazards: closure-list risk on any individual store, a guarantee from a leveraged private sponsor rather than a public balance sheet, and percentage-rent structures tied to declining pharmacy sales. Buyers are effectively underwriting store-level survivorship, and the store-level data (fill counts, script volume, lease clauses tied to closure) matters more than the corporate story.
Former Rite Aid properties have no tenant cap rate at all. They price on alternative-use economics, typically $1.0M–$3.5M for a 10,000–13,500 square foot dark prototype on a strong corner. Some carry leases assumed and assigned to acquirers in the bankruptcy, and any deal marketed today as a “Rite Aid NNN” requires document-level verification of who the obligor actually is. For redevelopment buyers, the real estate is the entire thesis: hard-corner parcels with drive-thru infrastructure suit urgent care, dental, QSR conversion, and discount retail.
Lease Structure: When 25 Years Stops Being an Asset
The legacy Walgreens lease is famous for its 25-year initial term, flat rent, and corporate guarantee. In the company’s investment grade era, that structure was prized as bond-like duration. Today the same structure cuts the other way: flat rent means no inflation protection while credit deteriorates, and long duration means more years of exposure to an obligor whose ratings no longer exist. Percentage-rent provisions tied to pharmacy revenue have declined with script migration, and large-format boxes with limited co-tenancy are expensive to backfill.
Rite Aid’s wind-down shows the end state. Leases were either rejected in bankruptcy, leaving landlords with unsecured claims and empty boxes, or assumed and assigned, leaving landlords with a different tenant on the old paper. Landlords who had underwritten the real estate, not just the guarantee, recovered fastest: strong corners re-leased to healthcare and QSR users, while weak sites in overbuilt corridors remain dark in 2026.
The Bond-to-NNN Pivot: No Investment Grade Paper Here
Neither company offers an investment grade bond alternative. Legacy Walgreens Boots Alliance bonds trade at high-yield spreads consistent with the withdrawn BB‑/Ba3 profile, and Rite Aid’s rated obligations were extinguished in the wind-down. Investors who want pharmacy exposure with an investment grade credit have exactly one national option: CVS, rated BBB/Baa3, whose bonds yield in the mid-5% area while CVS NNN properties trade near 6.4–7%, a spread with depreciation and 1031 benefits on top. The comparison framework lives on the investment grade bonds hub.
What Should Pharmacy NNN Investors Do in 2026?
Existing Walgreens landlords should verify whether their store appears on closure lists, pull recent script and sales data if percentage rent applies, and price an exit against the 8.6–9.5% market before the closure program advances further. A store that survives the cull on a strong corner may be a high-yield hold; a marginal store is a re-leasing project with a countdown clock.
Prospective buyers should treat Walgreens as special-situations investing, not passive credit investing, and treat former Rite Aid boxes as value-add real estate plays where the purchase price must make sense at local re-lease rents with realistic downtime and conversion costs.
1031 buyers seeking pharmacy income with actual credit have effectively one tenant left: CVS, the only investment grade drugstore chain still operating at national scale. The 200–300 basis point spread between CVS and Walgreens cap rates is the market’s price on that distinction.
Walgreens vs Rite Aid: Frequently Asked Questions
Is Walgreens investment grade in 2026?
No. Walgreens was rated BB‑/Ba3, below the BBB‑/Baa3 investment grade cutoff, before Sycamore Partners took it private in August 2025, and those ratings have since been withdrawn. Walgreens NNN properties trade at 8.6–9.5% cap rates reflecting elevated credit risk.
What happened to Rite Aid?
Rite Aid filed a second Chapter 11 on May 5, 2025 and wound down entirely, selling pharmacy scripts to CVS, Walgreens, Kroger, Albertsons, and Giant Eagle. All stores closed by October 2025. Its rating is D (default) and the corporate guarantee behind former leases was extinguished in bankruptcy.
Are Walgreens NNN properties a good investment in 2026?
Only for investors who underwrite them as special situations. The 8.6–9.5% cap rates compensate for closure risk on 1,200 stores, a leveraged private owner, and diminished guarantee value. Store-level performance, closure-list status, and residual real estate value matter more than the corporate brand.
What are former Rite Aid properties worth?
Former Rite Aid locations typically trade between $1.0M and $3.5M on alternative-use and redevelopment economics rather than tenant credit. Strong hard-corner sites with drive-thru infrastructure attract urgent care, dental, QSR, and discount retail conversions; weaker sites price as land.
Which pharmacy tenant is still investment grade?
CVS is the only national drugstore chain with investment grade ratings, at BBB from S&P and Baa3 from Moody’s. That is why CVS NNN properties trade 200–300 basis points tighter than Walgreens, in the 6.4–7% range.
Holding a Walgreens or a former Rite Aid, or weighing a distressed pharmacy deal? We underwrite store-level survivorship, re-lease scenarios, and exit pricing across the pharmacy sector. Request a consultation for a property-specific analysis.
Related Tenant & Sector Analysis
- Walgreens Credit Rating & NNN Cap Rate
- Rite Aid Credit Rating: D (Default) After 2025 Bankruptcy
- CVS vs Walgreens: Which NNN Investment Wins?
- Pharmacy NNN Cap Rates After Walgreens and Rite Aid Stress
- Pharmacy NNN Properties: Credit Risk, Closure Risk, and Reuse Value
- Investment Grade Credit Tenant Ratings Database
